行情

VNRX

VNRX

VOLITIONRX
AMEX
2.180
-0.030
-1.36%
交易中 09:56 11/29 EST
开盘
2.200
昨收
2.210
最高
2.200
最低
2.167
成交量
3,878
成交额
692
52周最高
3.570
52周最低
1.310
市值
1.25亿
市盈率(TTM)
-3.8105
分时
5日
1月
3月
1年
5年
暂无数据
VNRX 简况
VolitionRx Limited is a multi-national epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop blood tests to help diagnose and monitor a range of diseases, including certain cancers and diseases associated with NETosis, such as sepsis and COVID-19. The Company’s tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluids. Its Nucleosomics technology uses chromosomal structures called nucleosomes as biomarkers in cancer and other diseases. Its key pillars include Nu.Q , Nu.Q NETs, Nu.Q Capture, Nu.Q Discover and Nu.Q Vet. Its Nu.Q family of tests acts as an early warning system by monitoring treatment response, disease progression and remission. Its Nu.Q tests use epigenetic information from tumor cells nucleosomes that helps physicians select the treatment for each patient, monitor their response and disease progression.

微牛提供VolitionRX Ltd(AMEX-VNRX)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的VNRX股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易VNRX股票基本功能。